News

ANZUPGO® (delgocitinib) Cream Is Now the First and Only FDA-Approved Treatment for Moderate-to-Severe Chronic Hand Eczema (CHE) in Adults
LEO Pharma Inc. announced today that the Food and Drug Administration (FDA) has approved ANZUPGO® (delgocitinib) cream for ...
Fierce Pharma3d
Leo roars to key FDA nod for Anzupgo to treat chronic hand eczema
Danish dermatology specialist Leo Pharma has scored an FDA approval that makes its JAK inhibitor cream Anzupgo (del | Despite chronic hand eczema affecting 1 in 10 people worldwide, there was no ...
Healio3d
FDA approves Anzupgo for chronic hand eczema
The FDA approved Anzupgo for the treatment of moderate to severe chronic hand eczema in adults who do not adequately respond ...
Pharmabiz1d
US FDA approves LEO Pharma’s Anzupgo cream for the treatment of moderate-to-severe chronic hand eczema
Ballerup, Denmark Saturday, July 26, 2025, 15:00 Hrs [IST] ...
The Munich Eye2d
FDA Greenlights First-Ever Cream for Chronic Hand Eczema Treatment
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
PMLive3d
LEO’s Anzupgo granted FDA approval to treat moderate-to-severe chronic hand eczema
LEO Pharma’s Anzupgo (delgocitinib) cream has been approved by the US Food and Drug Administration (FDA) to treat adults with ...
The Pharma Letter3d
FDA green light for LEO’s Anzupgo
Privately-held Danish dermatology specialist LEO Pharma today revealed that the US Food and Drug Administration (FDA) has ...
FDA approves first cream for treating chronic hand eczema
The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic ...
WebMD3d
FDA OKs New Steroid-Free Skin Cream for Hand Eczema
The FDA has approved a new treatment, sold under the name Anzupgo and containing a drug called delgocitinib, as the first skin cream for adults with long-term or chronic hand eczema (CHE), which ...
Managed Healthcare Executive3d
Anzupgo FDA Approved as First Treatment Meant for Chronic Hand Eczema in Adults
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.
LEO Pharma Announces FDA Approval of ANZUPGO (delgocitinib) Cream in the U.S.
ANZUPGO (delgocitinib) cream now becomes the first and only FDA-approved treatment specifically approved for the treatment of adults living with moderate-to-severe chronic hand eczema (CHE) in the ...